LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

22 filings reported holding LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share as of Q3 2021.
LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8,217,728 shares of 26,019,256 outstanding shares and own 31.58% of the company stock.
Largest 10 shareholders include Novo Holdings A/S (3,327,312 shares), Redmile Group, LLC (2,816,196 shares), Nicholas Investment Partners, LP (528,953 shares), Nantahala Capital Management, LLC (369,290 shares), AXA S.A. (229,121 shares), SPHERA FUNDS MANAGEMENT LTD. (215,359 shares), Artal Group S.A. (200,000 shares), Falcon Edge Capital, LP (140,229 shares), DAFNA Capital Management LLC (139,332 shares), and Point72 Asset Management, L.P. (123,911 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.